Inactief instrument

Koers Trivascular Technologies Inc

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

TriVascular Technologies, Inc. Reports Third Quarter Financial Results	09-11-15
Preliminary Results of the LIFE Study Presented at VIVA 2015	03-11-15
Four-Year Results From Global Ovation Pivotal Trial Presented at VIVA 2015	03-11-15
Trivascular Technologies : Brower Piven Commences An Investigation Into The Proposed Sale Of TriVascular Technologies, Inc. And Encourages Investors To Contact The Firm For Additional Information	29-10-15
TRIVASCULAR TECHNOLOGIES : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Endologix, Inc. May be Unfair to Shareholders	28-10-15

Managers	Titel	Leeftijd	Van
John Onopchenko CEO	Chief Executive Officer	66	-
Vaseem Mahboob DFI	Director of Finance/CFO	55	03-02-16

Sector

	Vaira. 1 jan.	Kapi.
STRYKER CORPORATION	+12,07%	128 mld.
SMITH & NEPHEW PLC	-9,04%	10,65 mld.
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0,91%	8,82 mld.
INSPIRE MEDICAL SYSTEMS, INC.	+16,72%	7,19 mld.
GLAUKOS CORPORATION	+25,15%	4,99 mld.
AXONICS, INC.	+7,17%	3,4 mld.
ENOVIS CORPORATION	-1,36%	3,03 mld.
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8,73%	2,14 mld.
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10,15%	2 mld.